1 0

    EMIS +

    Executive Brain-Span Audit (MCI)

    Executive Brain-Span Audit (MCI)

    $179.00 SGD
    $179.00 SGD
    促销 售罄
    结账时计算的运费。
    Clinical Summary: The Executive Brain-Span Audit (MCI) is a clinical-grade cognitive screening service offered by EMIS+ in Singapore, designed to detect early-stage Mild Cognitive Impairment through standardised neuropsychological testing batteries covering executive function, memory recall, and processing speed. The assessment follows internationally recognised MCI diagnostic criteria aligned with the National Institute on Aging and Alzheimer's Association (NIA-AA) research framework. It is indicated for adults aged 40 and above seeking proactive cognitive health monitoring, particularly those with cardiovascular risk factors, family history of neurodegenerative disease, or occupational cognitive demands.

    Product Overview

    The Executive Brain-Span Audit (MCI) at EMIS+ is a comprehensive cognitive health assessment service available exclusively through emis.asia in Singapore. This clinical-grade screening protocol employs validated neuropsychological instruments to evaluate executive function, episodic memory, visuospatial ability, language fluency, and processing speed. The assessment generates a personalised brain longevity profile that quantifies cognitive reserve and identifies domains requiring targeted intervention.

    Early detection of Mild Cognitive Impairment represents a critical window for therapeutic intervention. Peer-reviewed longitudinal studies demonstrate that individuals identified at the MCI stage who receive structured cognitive rehabilitation, lifestyle modification, and pharmacological support where appropriate experience significantly better cognitive trajectories than those diagnosed after progression to dementia. The EMIS+ protocol integrates evidence-based screening methodologies consistent with NIA-AA 2018 research framework criteria and Singapore Ministry of Health (MOH) clinical practice guidelines for dementia management.

    Service Specifications

    Provider EMIS+ (Essential Medical International Supplies Pte Ltd), Singapore
    Assessment Type Neuropsychological Screening Battery — Mild Cognitive Impairment (MCI)
    Cognitive Domains Assessed Executive Function, Episodic Memory, Working Memory, Processing Speed, Visuospatial Function, Language Fluency
    Validated Instruments MoCA (Montreal Cognitive Assessment), Trail Making Test (TMT-A/B), Digit Span, Category Fluency
    Diagnostic Framework NIA-AA 2018 Research Framework; DSM-5 Mild Neurocognitive Disorder Criteria
    Target Population Adults aged 40+; individuals with cardiovascular risk factors, family history of neurodegeneration, or high cognitive occupational demands
    Delivery In-person clinical assessment, Singapore
    Output Personalised Brain Longevity Profile with domain-specific scoring and intervention recommendations
    Regulatory Alignment Singapore MOH Clinical Practice Guidelines on Dementia; NIA-AA 2018 Framework; ISO 15189 accredited laboratory partners where applicable
    Price SGD 179.00

    Clinical Indications

    • Proactive cognitive health screening for adults aged 40 and above as part of annual executive health programmes
    • Early detection of Mild Cognitive Impairment in individuals presenting with subjective memory complaints not yet meeting dementia diagnostic thresholds
    • Baseline cognitive profiling for patients initiating cardiovascular, metabolic, or neurological treatment protocols where cognitive monitoring is recommended
    • Post-concussion or post-anaesthetic cognitive function assessment to establish recovery benchmarks
    • Longitudinal cognitive monitoring for individuals with APOE-e4 carrier status or first-degree family history of Alzheimer disease
    • Occupational cognitive fitness evaluation for professionals in safety-critical roles (aviation, healthcare, finance)

    Frequently Asked Questions

    Q: What is the clinical basis for MCI screening at age 40?

    A: The NIA-AA 2018 research framework and epidemiological data from the Singapore Longitudinal Ageing Study (SLAS) indicate that subclinical cognitive changes can begin in the fourth decade. Early screening establishes a cognitive baseline that enables detection of meaningful decline over time, consistent with recommendations from the American Academy of Neurology (AAN) practice parameter on MCI.

    Q: Which neuropsychological instruments are used in this audit?

    A: The assessment employs internationally validated tools including the Montreal Cognitive Assessment (MoCA), Trail Making Test Parts A and B, Digit Span Forward and Backward, and Category Fluency testing. These instruments are recommended by the Singapore MOH Clinical Practice Guidelines on Dementia and align with NIA-AA core clinical criteria for MCI diagnosis.

    Q: How does this differ from a standard memory screening?

    A: Standard memory screenings such as the MMSE assess global cognitive function with limited sensitivity for MCI. The Executive Brain-Span Audit employs a multi-domain neuropsychological battery with specific attention to executive function — the cognitive domain most predictive of functional decline and occupational performance deterioration in early MCI presentations.

    Q: Is this assessment recognised by Singapore healthcare authorities?

    A: The screening instruments and diagnostic criteria used are consistent with Singapore Ministry of Health (MOH) Clinical Practice Guidelines on Dementia and internationally recognised frameworks (NIA-AA, DSM-5). Results can be shared with referring physicians for clinical decision-making and further diagnostic workup including neuroimaging if indicated.

    Q: Can I use MediFund, MediSave, or insurance to pay for this assessment?

    A: Cognitive screening services may qualify for reimbursement under certain private health insurance plans or corporate wellness programmes. MediSave coverage for cognitive screening is subject to MOH regulations and referring physician assessment. Please consult your insurance provider or contact EMIS+ at emis.asia for specific coverage enquiries.

    查看完整详细信息